(Q38912063)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470596%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

review article

1 reference

title

Cardiometabolic risk and gut microbial phytoestrogen metabolite phenotypes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470596%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470596%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Cara L Frankenfeld

series ordinal

1

1 reference

7 September 2017

30 August 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470596%20AND%20SRC:MED&resulttype=core&format=json

Molecular Nutrition and Food Research

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470596%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470596%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470596%20AND%20SRC:MED&resulttype=core&format=json

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

The contributory role of gut microbiota in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Diversity, stability and resilience of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Functional intestinal microbiome, new frontiers in prebiotic design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

A metagenomic β-glucuronidase uncovers a core adaptive function of the human intestinal microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Functional metagenomics to mine the human gut microbiome for dietary fiber catabolic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Comparative metagenomics and population dynamics of the gut microbiota in mother and infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Taking a metagenomic view of human nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Inter-individual differences in response to dietary intervention: integrating omics platforms towards personalised dietary recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Toward personalized nutrition: comprehensive phytoprofiling and metabotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Potential risks and benefits of phytoestrogen-rich diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Phyto-oestrogens: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Phytoestrogens and their effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Molecular aspects of phytoestrogen selective binding at estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Bioactivation of Phytoestrogens: Intestinal Bacteria and Health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Microbial biotransformation of bioactive flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Deglycosylation of isoflavone C-glycosides by newly isolated human intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Estimated Asian adult soy protein and isoflavone intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Urinary isoflavones and their metabolites validate the dietary isoflavone intakes in US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Validation of a soy food frequency questionnaire with plasma concentrations of isoflavones in US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Assessing phytoestrogen exposure in epidemiologic studies: development of a database (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Human intestinal bacterium, strain END-2 is responsible for demethylation as well as lactonization during plant lignan metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Biotransformation of Pinoresinol Diglucoside to Mammalian Lignans by Human Intestinal Microflora, and Isolation of Enterococcus faecalis Strain PDG-1 Responsible for the Transformation of (+)-Pinoresinol to (+)-Lariciresinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

O-desmethylangolensin: the importance of equol's lesser known cousin to human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Equol production changes over time in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Equol production changes over time in pre-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Synthesis of isoflavone aglycones and equol in soy milks fermented by food-related lactic acid bacteria and their effect on human intestinal Caco-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Biotransformation of C-glucosylisoflavone puerarin to estrogenic (3S)-equol in co-culture of two human intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Frequency of soy food consumption and serum isoflavone concentrations among Chinese women in Shanghai

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Soy and Soy Products Intake, All-Cause Mortality, and Cause-Specific Mortality in Japan: The Jichi Medical School Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Soy product consumption and the risk of colon cancer: a prospective study in Takayama, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Dairy consumption is a significant correlate of urinary equol concentration in a representative sample of US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Soya isoflavone consumption in relation to carotid intima-media thickness in Chinese equol excretors aged 40-65 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Daidzein-metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Daidzein supplementation decreases serum triglyceride and uric acid concentrations in hypercholesterolemic adults with the effect on triglycerides being greater in those with the GA compared with the GG genotype of ESR-β RsaI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Urinary phytoestrogens in relation to metabolic disturbances among children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Urinary isoflavone concentrations are inversely associated with cardiometabolic risk markers in pregnant U.S. women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Urinary enterolactone is associated with obesity and metabolic alteration in men in the US National Health and Nutrition Examination Survey 2001-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Probiotic Soy Product Supplemented with Isoflavones Improves the Lipid Profile of Moderately Hypercholesterolemic Men: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Equol status and blood lipid profile in hyperlipidemia after consumption of diets containing soy foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Soy food consumption, cardiometabolic alterations and carotid intima-media thickness in Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Dietary lignans: physiology and potential for cardiovascular disease risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Quantification of a broad spectrum of lignans in cereals, oilseeds, and nuts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Phenol-Explorer: an online comprehensive database on polyphenol contents in foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Urinary phytoestrogen concentrations in the U.S. population (1999-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Enterolignan-producing phenotypes are associated with increased gut microbial diversity and altered composition in premenopausal women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

A randomized controlled trial of the effects of flaxseed lignan complex on metabolic syndrome composite score and bone mineral in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Meta-analysis of the effects of flaxseed interventions on blood lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Sesame supplementation does not improve cardiovascular disease risk markers in overweight men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Relationship of obesity and high urinary enterolignan concentrations in 6806 children and adults: analysis of National Health and Nutrition Examination Survey data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Cardiometabolic risk factors are associated with high urinary enterolactone concentration, independent of urinary enterodiol concentration and dietary fiber intake in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Urinary enterolactone associated with liver enzyme levels in US adults: National Health and Nutrition Examination Survey (NHANES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

The association between urinary phytoestrogen excretion and components of the metabolic syndrome in NHANES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Urinary enterolignan concentrations are positively associated with serum HDL cholesterol and negatively associated with serum triglycerides in U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of U.S. women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

A Prospective Investigation of the Association Between Urinary Excretion of Dietary Lignan Metabolites and Weight Change in US Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Microbial metabolomic fingerprinting in urine after regular dealcoholized red wine consumption in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Epicatechin, procyanidins, and phenolic microbial metabolites after cocoa intake in humans and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Metabolism of isoflavones, lignans and prenylflavonoids by intestinal bacteria: producer phenotyping and relation with intestinal community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

Role of bifidobacteria in the activation of the lignan secoisolariciresinol diglucoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500900

21 January 2018

Identifiers

DOI

10.1002/MNFR.201500900

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27470596%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference